MEDICINES Australia says Australia's Productivity Commission "continues to misunderstand the value of intellectual property (IP)" after a report which recommended reductions on protection for patented drugs in Australia.
The pharmaceutical peak body said "watering down Australia's existing IP regime puts at risk early access to medical innovation by Australians, as it will become unviable to bring a new product directly to market in Australia".
MA urged the government to dismiss the recommendations.
The above article was sent to subscribers in Pharmacy Daily's issue from 21 Dec 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 21 Dec 16
